Factors associated with negative conversion of viral RNA in patients hospitalized with COVID-19

被引:98
作者
Hu, Xiaowen [1 ]
Xing, Yuhan [2 ]
Jia, Jing [1 ]
Ni, Wei [3 ]
Liang, Jiwei [1 ]
Zhao, Dan [1 ]
Song, Xin [1 ]
Gao, Ruqin [1 ]
Jiang, Fachun [1 ]
机构
[1] Municipal Ctr Dis Control & Prevent Qingdao, Qingdao Inst Prevent Med, 175 Shandong Rd, Qingdao 266033, Shandong, Peoples R China
[2] Chinese Univ Hong Kong, Fac Med, Dept Paediat, Hong Kong, Peoples R China
[3] Qingdao Univ, Qingdao Women & Childrens Hosp, Qingdao, Shandong, Peoples R China
关键词
Coronavirus disease 2019 (COVID-19); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Negative conversion; Hazard ratio; LOAD;
D O I
10.1016/j.scitotenv.2020.138812
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Factors associated with negative conversion of SARS-CoV-2 RNA in hospitalized patients have not yet been systematically determined. We conducted a retrospective cohort study of COVID-19 patients in Qingdao, China. Both univariate and multivariate analysis were performed to identify independent factors for time to viral RNA negative conversion. Data on patients with re-detectable viral RNA after showing negative on RT-PCR test (intermittent negative status) were also analyzed. A total of 59 patients confirmed with COVID-19 were included in this study, with a median duration of 1 (interquartile range, IQR: 0-2) day from symptom onset to hospital admission. Median communicable period (from first day of positive nucleic acid test to first day of consecutive negative results) was 14 (IQR: 10-18) days, and 7 (IQR: 6-10) days for 10 patients with intermittent negative results. Age older than 45 years (hazard ratio, HR: 0.378; 95% confidence interval, CI: 0.205-0.698) and chest tightness (HR: 0.290; 95%CI: 0.091-0.919) were factors independently affecting negative conversion of SARS-CoV-2 RNA. Headache (odds ratio: 7.553; 95%CI: 1.011-28.253) was significantly associated with intermittent negative status, with a predicted probability of 60%. Older age and chest tightness were independently associated with delayed clearance of SARS-CoV-2 RNA in hospitalized patients. These predictors would provide a new perspective on early identification of patients with prolonged viral shedding and facilitate optimal isolation protocols and treatment strategies.
引用
收藏
页数:7
相关论文
共 27 条
[1]  
An J, 2020, 20044222 MEDRXIV
[2]  
[Anonymous], COR DIS COVID 19 STA
[3]   Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases [J].
Ai, Tao ;
Yang, Zhenlu ;
Hou, Hongyan ;
Zhan, Chenao ;
Chen, Chong ;
Lv, Wenzhi ;
Tao, Qian ;
Sun, Ziyong ;
Xia, Liming .
RADIOLOGY, 2020, 296 (02) :E32-E40
[4]   Risk of sars transmission to persons in close contact with discharged patients [J].
Chan, LY ;
Li, PKT ;
Sung, J .
AMERICAN JOURNAL OF MEDICINE, 2003, 115 (04) :330-330
[5]   Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study [J].
Chen, Nanshan ;
Zhou, Min ;
Dong, Xuan ;
Qu, Jieming ;
Gong, Fengyun ;
Han, Yang ;
Qiu, Yang ;
Wang, Jingli ;
Liu, Ying ;
Wei, Yuan ;
Xia, Jia'an ;
Yu, Ting ;
Zhang, Xinxin ;
Zhang, Li .
LANCET, 2020, 395 (10223) :507-513
[6]   Nasopharyngeal shedding of severe acute respiratory syndrome-associated coronavirus is associated with genetic polymorphisms [J].
Chen, WJ ;
Yang, JY ;
Lin, JH ;
Fann, CSJ ;
Osyetrov, V ;
King, CC ;
Chen, YMA ;
Chang, HL ;
Kuo, HW ;
Liao, F ;
Ho, MS .
CLINICAL INFECTIOUS DISEASES, 2006, 42 (11) :1561-1569
[7]   Duration of RT-PCR positivity in severe acute respiratory syndrome [J].
Chu, CM ;
Leung, WS ;
Cheng, VCC ;
Chan, KH ;
Lin, AWN ;
Chan, VL ;
Lam, JYM ;
Chan, KS ;
Yuen, KY .
EUROPEAN RESPIRATORY JOURNAL, 2005, 25 (01) :12-14
[8]   Initial viral load and the outcomes of SARS [J].
Chu, CM ;
Poon, LLM ;
Cheng, VCC ;
Chan, KS ;
Hung, IFN ;
Wong, MML ;
Chan, KH ;
Leung, WS ;
Tang, BSF ;
Chan, VL ;
Ng, WL ;
Sim, TC ;
Ng, PW ;
Law, KI ;
Tse, DMW ;
Peiris, JSM ;
Yuen, KY .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2004, 171 (11) :1349-1352
[9]   A systematic review on the ef ficacy and safety of chloroquine for the treatment of COVID-19 [J].
Cortegiani, Andrea ;
Ingoglia, Giulia ;
Ippolito, Mariachiara ;
Giarratano, Antonino ;
Einav, Sharon .
JOURNAL OF CRITICAL CARE, 2020, 57 :279-283
[10]  
Gao W J, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P485, DOI 10.3760/cma.j.cn112338-20200228-00207